Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de James B. Breitmeyer
Age : 66
Public asset : 964,011 USD
Linked companies : Zogenix, Inc. - Oncternal Therapeutics, Inc. - Otonomy, Inc.
Founder of Oncternal Therapeutics, Inc., James B. Breitmeyer is an American businessperson who has been at the head of 5 different companies and is President, Chief Executive Officer & Director at this company and Chief Executive Officer for Oncternal Oncology, Inc. (a subsidiary of Oncternal Therapeutics, Inc.).

He is also on the board of Zogenix, Inc. and Otonomy, Inc.

James B. Breitmeyer previously occupied the position of Chief Medical Officer, Head-R&D at Serono International SA, Executive Vice President for Bavarian Nordic An and President for Bavarian Nordic, Inc. (a subsidiary of Bavarian Nordic A), President, Chief Executive Officer & Director at Tokalas, Inc., Chief Medical Officer & Vice President at Applied Molecular Evolution, Inc., Chief Medical Officer & Executive VP-Development at Mallinckrodt Hospital Products, Inc., Chief Medical Officer at EMD Serono, Inc., Chief Medical Officer & Senior Vice President for Merck Serono SA and President & Chief Executive Officer for The Baim Institute for Clinical Research.

He received a doctorate from Washington University School of Medicine and an undergraduate degree from the University of California, Santa Cruz.

Current positions of James B. Breitmeyer 
NameTitle Since
Zogenix, Inc.
Independent Director 2014
Oncternal Therapeutics, Inc.
(Biotechnology & Medical Research)
President, Chief Executive Officer & Director 2015
Otonomy, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Oncternal Oncology, Inc. Chief Executive Officer -

Holdings of James B. Breitmeyer 
Oncternal Therapeutics, Inc. (ONCT)
(Biotechnology & Medical Research)
257,4520.52%944,849 USD
Zogenix, Inc. (ZGNX)
1,2500.0022%19,163 USD
Otonomy, Inc. (OTIC)
(Biotechnology & Medical Research)
00.0000%0 USD

James B. Breitmeyer: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
02:26pELON MUSK : Tesla's Musk says Biden's electric vehicle bill should not pass Congress
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
More news

© 2021 People and Ownership :   
James B. Breitmeyer : Connections